Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 23 ... Pharmaceutical, FDA, Electronics, Analogue, Food, Antimetabolite, Antineoplastic, Antiviral, Cancer, Clinical Trial Research, Cutaneous T-Cell Lymphoma, Gemcitabine, Hematology, ... Administration's accelerated approval of FOLOTYN™ on September 24, 2009, for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL). In addition, ...
2009 NOV 23 ... Chimerix, Inc., a biopharmaceutical company advancing orally-available antiviral therapeutics to address life-threatening diseases, announced that Kenneth I. Moch, Chief ... and pipeline, including CMX001, a broad-spectrum antiviral being developed for the treatment of BK virus and cytomegalovirus in immunocompromised transplant patients and as a ...
2009 NOV 23 ... certain key hydrogen atoms of atazanavir with deuterium. In preclinical studies, the antiviral potency of atazanavir was fully retained but with markedly slower hepatic metabolism, ... 1b clinical study with CTP-518, its investigational oral HIV protease inhibitor for the treatment of HIV infection. In connection with the start of this multiple ascending dose arm of ...
2009 NOV 23 ... Sweden report. "Combination therapy including LV-antiserum and an antiviral drug, Pleconaril, significantly reduced the levels of blood glucose and insulin and the ... Country:Sweden, Antiviral, Combination Therapy, Diabetes, Gastroenterology, Immunology, Treatment, Viral Inhibition, Viral Therapy, Virology. This article was prepared by ...
2009 NOV 28 ... continue to make progress on all fronts, including the advancement of our differentiated antiviral development programs and most recently, the completion of a financing that we believe ... Phase II clinical trial to evaluate the safety and biologic activity of FV-100 for the treatment of shingles. INX -189 -During the third quarter, the Company advanced INX-189, its lead ...
2009 NOV 23 ... is a discovery-stage biotechnology company focused on the development of new types of antiviral and autoimmune drugs. The Kineta team has a track record of developing novel drug ... Oncology, Pharmaceuticals, Pharmacology, Pre-Trials Research, Retinoic Acid, Therapy, Treatment, Vaccines, Virology, Kineta Inc. This article was prepared by AIDS Vaccine ...
2009 NOV 23 ... fusion inhibitor, now called MDT-637. This highly potent compound has demonstrated antiviral activity in preclinical studies in both prophylaxis and treatment, and was generally ...
2009 NOV 27 ... concluded: "The prepared family of the target nucleosides was tested for cytostatic and antiviral activity."Sala and colleagues published their study in Tetrahedron ... Republic, Life Sciences, Virology, Coxsackie Virus, Viral Research, Therapy, Treatment, Nucleoside Analog, Organic Chemistry.This article was prepared by Chemicals ...
2009 NOV 23 ... The researchers concluded: "Following the demonstration of a more potent antiviral effect in terms of sustained virological response rates in Phase III randomized trials, ... reducing the risk of liver-related complications. The latest innovation in anti-HCV treatment has been the pegylation of the IFN molecule through the attachment of one or more ...
2009 NOV 23 ... for testing and biosafety requirements necessary to safely handle it, In this study, the antiviral activity of standard household products was assayed against murine hepatitis virus ... Hepatitis, Infectious Disease, SARS, Severe Acute Respiratory Syndrome, Treatment, Viral Inhibition, Viral Therapy, Virology. This article was prepared by ...
2009 NOV 23 ... Affairs. "These data support the unique dual activities of DAS181. Because of its antiviral and anti-asthmatic properties, DAS181 may provide an alternative influenza treatment ...
2009 NOV 23 ... derived from lymphocytic choriomeningitis virus (LCMV) and evaluated its potency as an antiviral vaccine. The intramuscular immunization of mice with the peptide-liposome conjugates ... City:Moroyama, Country:Japan, Antivirals, Antiviral, Biotechnology, Immunology, Treatment, Vaccines, Viral Inhibition, Viral Therapy, Virology. This article was ...
2009 NOV 23 ... "A small-animal model for HCV infection would significantly expedite antiviral compound development and preclinical testing, as well as open new avenues to decipher ... C Virus, Hepatology, Immunization, Infectious Disease, Interferon, Pre-Trials Research, Treatment, Vaccines, Viral Inhibition, Viral Therapy, Virology. This article was ...
2009 NOV 23 ... treatment of multiple sclerosis (MS). it is believed that immunomodulatory rather than antiviral activity of interferon beta is responsible for disease amelioration. The impact of ...
2009 NOV 23 ... Drug Effect, Adverse Drug Event, Adverse Drug Reaction, Antimetabolite, Antineoplastic, Antiviral, Breast Cancer, Breast Carcinoma, Clinical Oncology, Clinical Trial Research, ... New research, 'Phase II study of gemcitabine monotherapy as a salvage treatment for Japanese metastatic breast cancer patients after anthracycline and taxane ...
2009 NOV 23 ... Therapy, Acinar Cell Cancer, Acinar Cell Carcinoma, Antimetabolite, Antineoplastic, Antiviral, Clinical Oncology, Gastroenterology, Gemcitabine, Immunosuppressant, Oncology, ... "The clinical features, especially those related to the prognosis and treatment outcomes, have not yet been fully clarified. There are no established treatments for ...
2009 NOV 23 ... use disorders, patients with these comorbidities have historically been excluded from antiviral therapy for HCV. The authors compared antiviral completion and sustained virologic ... of control subjects. Neuropsychiatric side effects and reasons for discontinuation of treatment were not different between groups," wrote P. Hauser and colleagues. The ...
2009 NOV 23 ... (RAMs) were investigated by analysing 6072 genotypic tests." "The antiviral activity of ETV was predicted using different interpretation systems: International AIDS ... New research, 'Prevalence of etravirine mutations and impact on response to treatment in routine clinical care: the Swiss HIV Cohort Study (SHCS),' is the subject of a ...
